Sze Hwei Lee¹, Chang-Tsu Yuan¹, Yuan-Yeh Kuo², Rung-Jing Chiou², Yi-Kuang Chuang², Hwei-Fang Tien¹, Tai-Chung Huang¹, Jih-Luh Tang² (1.National Taiwan University Hospital, Taipei, Taipei, Taiwan, 2.Tai-Cheng Stem Cell Therapy Center, National Taiwan University, Taipei, Taiwan, Taipei, Taipei, Taiwan)

Kanya Kondoh¹, Kazuaki Yokoyama^1,2, Nozomi Yusa³, Mika Ito¹, Eigo Shimizu⁴, Sousuke Nakamura¹, Miho Ogawa¹, Tomomi Takei¹, Asako Kobayashi¹, Rika Kasajima⁵, Yuka Wada⁶, Rui Yamaguchi⁷, Seiya Imoto⁵, Tokiko Nagamura⁶, Kaoru Uchimaru⁸, Satoru Miyano^4,5, Arinobu Tojo^1,2 (1.Division of Molecular Therapy, IMSUT, University of Tokyo, 2.Department of Hematology/Oncology, IMSUT Hospital, University of Tokyo, 3.Department of Applied Genomics, IMSUT Hospital, University of Tokyo, 4.Laboratory of DNA Information Analysis, IMSUT, University of Tokyo, 5.Health Intelligence Center, IMSUT, University of Tokyo, 6.Department of Cell Processing and Transfusion, IMSUT, University of Tokyo, 7.Division of Cancer Systems Biology, Aichi Cancer Center Research Institute, 8.Graduate School of Frontier Sciences, University of Tokyo)

Akio Mori^1,8, Masahiro Onozawa^2,8, Daisuke Hidaka^2,8, Shinpei Harada^1,8, Reiki Ogasawara^1,8, Koh Izumiyama^1,8, Makoto Saito^1,8, Masanori Tanaka^1,8, Yutaka Tsutsumi^3,8, Shuichi Ota^4,8, Takuto Miyagishima^5,8, Yasutaka Kakinoki^6,8, Hiroshi Iwasaki^7,8, Masanobu Morioka^1,8, Takanori Teshima^2,8, Takeshi Kondo^1,8 (1.Blood Disorders Center, Aiiku Hospital, Sapporo, Japan, 2.Dept. of Hematology, Faculty of Medicine, Hokkaido University, Sapporo, Japan, 3.Dept. of Hematology, Hakodate Municipal Hospital, Hakodate, Japan, 4.Dept. of Hematology, Sapporo Hokuyu Hospital, Sapporo, Japan, 5.Dept. of Hematology, Kushiro Rosai Hospital, Kushiro, Japan, 6.Dept. of Hematology, Asahikawa City Hospital, Asahikawa, Japan, 7.Dept. of Hematology, Sapporo Kosei Hospital, Sapporo, Japan, 8.North Japan Hematology Study Group; NJHSG, Sapporo, Japan)

TaeHyung Kim^1,2, Jae-Sook Ahn^1,3,4, Sung-Hoon Jung³, Seo-Yeon Ahn³, Seung-Yeon Jung³, Deok-Hwan Yang³, Je-Jung Lee³, SeungHyun Choi⁴, Ja-Yeon Lee⁴, Seong-Kyu Park⁵, Hui Young Lee^6,7, Kyoungha Kim^7,8, Yu Cai^7,9, Zhaolei Zhang^1,2,10, Hyeoung-Joon Kim^3,4, Dennis Dong Hwan Kim⁷ (1.The Donnelly Centre for Cellular and Biomolecular Research, University of Toronto, Toronto, Ontario, Canada, 2.Department of Computer Science, University of Toronto, Toronto, Ontario, Canada, 3.Department of Hematology-Oncology, Chonnam National University Hwasun Hospital, Hwasun, Jeollanam-do, Republic of Korea, 4.Genomic Research Center for Hematopoietic Diseases, Chonnam National University Hwasun Hospital, Hwasun, Jeollanam-do, Republic of Korea, 5.Department of Hematology-Oncology, Soonchunhyang University Bucheon Hospital, Bucheon, Gyeonggi-do, Republic of Korea, 6.Department of Internal Medicine, Kangwon National University Hospital, Chuncheon, Gangwon-do, Republic of Korea, 7.Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada, 8.Department of Internal Medicine, Soonchunhyang University Hospital, Seoul, Seoul, Republic of Korea, 9.Department of Hematology, Shanghai General Hospital affiliated to Shanghai Jiaotong University, Shanghai, Shanghai, People's Republic of China, 10.Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada)

Taisuke Narazaki¹, Yasuhiro Nakashima¹, Hiroki Muta¹, Mariko Tsuda¹, Toru Masuda¹, Daisaku Kimura¹, Akiko Takamatsu¹, Yuichiro Semba², Junpei Nogami², Toshihiro Miyamoto², Takahiro Maeda³, Motoaki Shiratsuchi¹, Yoshihiro Ogawa¹ (1.Department of Medicine and Bioregulatory Science, Kyushu University, Fukuoka, Japan, 2.Department of Medicine and Biosystemic Science, Kyushu University, Fukuoka, Japan, 3.Center for Cellular and Molecular Medicine, Kyushu University, Fukuoka, Japan)

Haruka Arai¹, Satoshi Wakita¹, Toshimitsu Ueki², Kensuke Usuki³, Yutaka Kobayashi⁴, Kenji Tajika⁵, Saiko Kurosawa⁶, Masayuki Kanda¹, Atsushi Marumo¹, Ikuko Omori¹, Masahiro Sakaguchi¹, Yusuke Fujiwara¹, Shunsuke Yui¹, Kazuki Terada¹, Kunihito Arai¹, Tomoaki Kitano¹, Takahiro Fukuda⁶, Koichi Inokuchi¹ (1.Department of Hematology, Nippon Medical School, Tokyo, Japan, 2.Department of Hematology, Nagano Red Cross Hospital, Nagano, Japan, 3.Department of Hematology, NTT Medical Center Tokyo, Japan, 4.Department of Hematology, Kyoto Second Red Cross Hospital, Kyoto, Japan, 5.Department of Hematology, Yokohama Minami Kyousai Hospital, Kanagawa, Japan, 6.Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan)